Novonesis provided earnings guidance for the year 2024. For the year, the company expects 5% to 7% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
383.6 DKK | -1.29% | -1.26% | +3.37% |
Apr. 30 | Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023 | CI |
Apr. 08 | Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.37% | 25.88B | |
-6.69% | 4.13B | |
+11.09% | 1.72B | |
-18.40% | 583M | |
-17.62% | 429M | |
-81.65% | 216M | |
-12.38% | 113M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novonesis Provides Earnings Guidance for the Year 2024